Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation.
Benazzo A, Cho A, Nechay A, Schwarz S, Frommlet F, Wekerle T, Hoetzenecker K, Jaksch P.
Benazzo A, et al.
Trials. 2021 Jan 4;22(1):6. doi: 10.1186/s13063-020-04843-9.
Trials. 2021.
PMID: 33397442
Free PMC article.
Clinical Trial.
The hypothesis driving the proposed clinical trial is that de novo introduction of low-dose everolimus early after transplantation could further improve kidney function via a further reduction of tacrolimus. Based on evidences from kidney transplantation, moreover, alemtuz …
The hypothesis driving the proposed clinical trial is that de novo introduction of low-dose everolimus early after transplantation could fur …